IP Library › Granted Patent US 7,897,354
Granted Patent B2
US 7,897,354 · App. 12/080,868 · Granted Mar 1, 2011

Kinase peptides and antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,354
App. No.
12/080,868
Granted
Mar 1, 2011
Kind
B2
Abstract

The invention relates to novel kinase peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of a kinase-mediated disease, as well as for determining or monitoring the efficacy of treatment.

Claims (4)

1. An isolated polyclonal antibody specifically reactive with a kinase peptide consisting of a sequence selected from the group consisting of SEQ ID NOs. 8-13 and 16-23.

2. An isolated polyclonal antibody obtained by a method comprising the steps of:

a) contacting a mammal with at least one kinase peptide consisting of a sequence selected from the group consisting of SEQ ID NOs. 8-13 and 16-23; and

b) collecting antiserum containing the polyclonal antibody from the mammal.

Assignments (2)
COURT ORDER Recorded Jun 1, 2017
From: NUCLEA BIOTECHNOLOGIES, INC.
To: NMDX, LLC
Reel/Frame 042562/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2008
From: MURACA, PATRICK J.
To: NUCLEA BIOMARKERS, LLC
Reel/Frame 020815/0575 →